Introduction {#s02}
============

One of the greatest feats of nature is that a single cell is able to activate an orchestrated developmental program that culminates in a complete multicellular organism. This property is the strictest definition of totipotency ([@bib23]) and can be attributed to cells of the early embryo. A one-cell embryo (zygote) is generated by the fusion of terminally differentiated haploid gametes, namely, egg (oocyte) and sperm ([Fig. 1](#fig1){ref-type="fig"}). Epigenetic reprogramming, zygotic genome activation (ZGA), and several cleavage divisions give rise to the cells of the mammalian embryo (blastomeres) that specialize into the embryo proper and extraembryonic tissues to form an organism. Totipotency of the blastomeres is gradually lost during cleavage divisions to allow cell specification and differentiation ([Fig. 1](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}).

![**Overview of molecular events during mouse gametogenesis and preimplantation development.** Male and female gametogenesis entail distinct timings of meiotic divisions (MI and MII) in relation to transcriptional activity and differentiation. The sperm genome is packaged around protamines that are rapidly exchanged to maternal histones at fertilization. Fertilization triggers resumption of oocyte meiosis (MII), and the totipotent zygote forms, containing two parental pronuclei. Totipotency declines with subsequent cleavage divisions. Maternal transcripts are rapidly degraded before ZGA, which occurs in two waves: minor ZGA in the late zygote and major ZGA in the two-cell embryo. DNA methylation dynamically changes in the zygote: paternal 5mC is lost, de novo paternal 5hmC forms, and passive dilution of DNA methylation occurs during cleavage divisions. Sp., spermatocyte.](JCB_201807044_Fig1){#fig1}

###### Comparison of timings in human and mouse preimplantation development.

                                     **Human**                                                                                                                **Mouse**
  ---------------------------------- ------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------
  First cleavage division            27 to 30 hpf ([@bib107]; [@bib160]; [@bib91])                                                                            16 to 20 hpf ([@bib5]; [@bib91])
  Blastocyst implantation            6 to 8 dpf ([@bib63])                                                                                                    4 to 4.5 dpf ([@bib42])
  Totipotent embryo                  Up to four-cell ([@bib156])                                                                                              Up to two-cell ([@bib150]; [@bib129])
  Major ZGA                          Four- to eight-cell ([@bib151]; [@bib17]; [@bib35]; [@bib157]; [@bib169])                                                Two-cell ([@bib43]; [@bib4]; [@bib58])
  DNA demethylation                  Before two-cell ([@bib55])                                                                                               In early one-cell ([@bib105]; [@bib119])
  Chromatin accessibility            Increases during cleavage stages; detectable promoter accessibility correlates with timing of ZGA ([@bib50]; [@bib97])   Increases during cleavage stages; detectable promoter accessibility correlates with timing of ZGA ([@bib101]; [@bib165])
  Higher-order chromatin structure   No data available                                                                                                        Gradual establishment during cleavage stages ([@bib38]; [@bib44]; [@bib51]; [@bib86])

dpf, days post-fertilization; hpf, hours post-fertilization.

One intriguing question in developmental biology is the following: What defines the chromatin state of a totipotent cell, and how does this determine the acquisition of totipotency? A comprehensive understanding of the nuclear and chromatin organization of the early embryo will provide crucial insights into the fundamental process of embryonic development and the complex network regulating cell identity and plasticity. The latter is of substantial interest considering the current limitations of cellular reprogramming, such as the generation of induced pluripotent stem cells, which is envisioned as a therapeutic tool for regenerative medicine ([@bib127]; [@bib116]; [@bib145]).

The rising era of low-input genomic assays sets the stage for exploring the regulatory networks for acquisition of totipotency in sparsely available early embryos. This review will summarize aspects of chromatin reprogramming occurring in the totipotent mouse embryo with a focus on insights gained from recent technical advances relating to zygotic DNA methylation dynamics, chromatin conformations, and chromatin accessibility status. Of note, available data from early human embryos indicate that chromatin reprogramming events occur with different timings compared to mouse embryos ([Table 1](#tbl1){ref-type="table"}). Furthermore, the lineage-specific transcriptional program responsible for patterning the embryo differs substantially between mouse and human ([@bib46]; [@bib115]; [@bib45]). This suggests distinct fine-tuning of epigenetic and chromatin profiles that awaits further analysis in the human embryo.

Zygotic reprogramming: The first hours after fertilization {#s03}
==========================================================

Dynamic changes in epigenetic marks that occur throughout zygotic interphase are thought to promote the acquisition of totipotency. These involve histone incorporation, establishment of histone modifications, timely changes in the DNA methylation status, changes in chromatin accessibility, and changes in three-dimensional chromatin conformations. The complex cellular events occurring after fertilization can be summarized as the "oocyte-to-zygote transition." It is thought that maternal factors stored in the oocyte are important for this transition due to limited transcription in the first cell cycle after fertilization in mammals ([@bib148]; [@bib83]). Vertebrate ZGA occurs in waves, with the major activation occurring at the two-cell stage in mouse ([@bib43]; [@bib4]; [@bib58]).

After fertilization, the parental genomes form two spatially separate entities---the maternal and paternal pronucleus. The cellular histories of the parental genomes are quite different ([Fig. 1](#fig1){ref-type="fig"}). Maternal chromosomes of the meiosis II oocyte are condensed, and fertilization triggers resumption of the second meiotic division, followed by decondensation and formation of interphase chromatin comprising the maternal pronucleus. Maternal chromatin is packaged with predeposited maternal histones and is segregated during the meiotic divisions in the absence of transcription ([@bib6]; [@bib15]). On the other hand, meiotic divisions during spermatogenesis are followed by active transcription ([@bib87]), with subsequent protamine packaging of the paternal chromatin ([@bib106]; [@bib118]; [@bib126]). In mice, ∼2--4% of the histones are retained in sperm ([@bib10]; [@bib21]). Shortly after fertilization, the protamines are exchanged to maternal histones containing the histone variant H3.3 ([@bib155]; [@bib152]), and the paternal chromatin decompacts to an interphase state ([@bib128]).

Additionally, the epigenetic signatures differ in the parental genomes. Histones of the paternal genome are initially mainly hypomethylated and hyperacetylated, while the maternal genome is enriched with repressive histone lysine methylation marks (reviewed in [@bib20]; [@bib41]; [@bib168]). Furthermore, DNA methylation underlies dynamic and parental specific events that will be discussed in detail. In brief, paternal DNA becomes demethylated, which is characterized by reduction of 5-methylcytosine (5mC; [@bib105]; [@bib119]) and acquires 5-hydroxymethylcytosine (5hmC; [@bib53]; [@bib68]; [@bib73]; [@bib163]). In contrast, maternal DNA retains a higher 5mC level and does not gain notable de novo 5hmC. The functional significance of these epigenetic asymmetries remains to be determined.

Epigenetics of the early embryo: The complexity of zygotic DNA demethylation {#s04}
============================================================================

In many eukaryotic clades, DNA methylation occurs at cytosine (5mC) of cytosine-guanine dinucleotides (CpG). This epigenetic modification correlates with gene repression in mammals, such as stable silencing of repetitive DNA, imprinting, and X chromosome inactivation ([@bib82]; [@bib135]). De novo establishment of 5mC is catalyzed by DNA methyltransferases (DNMTs) 3a, 3b, and 3c ([@bib117]; [@bib7]; [@bib78]), while maintenance of 5mC throughout cell divisions is mediated by DNMT1 ([@bib96]). Loss of DNA methylation can proceed either by passive or active mechanisms. Passive dilution of 5mC occurs over consecutive cell cycles during DNA replication in the absence of maintenance DNMT, DNMT1 ([@bib130]). Active DNA demethylation mechanisms, which refer to enzyme-mediated changes in 5mC to other cytosine modifications or reversal to unmodified cytosine, can involve Ten-eleven translocation (Tet) methylcytosine dioxygenases ([@bib164]). Tet family proteins iteratively convert 5mC to 5hmC, 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC; [@bib149]; [@bib61]; [@bib75]; [Fig. 2](#fig2){ref-type="fig"}). Studies in mouse embryonic stem cells (mESCs) demonstrated that oxidized cytosines can be passively diluted but are also substrates for thymine-DNA glycosylase, which recognizes oxidized cytosines and generates an abasic site that is perceived by the base excision repair (BER) machinery, resulting in active DNA demethylation ([@bib25]; [@bib61]).

![**Proposed mechanisms of zygotic DNA demethylation.** Passive DNA demethylation mechanisms include (i) replication-dependent passive dilution of 5mC or (ii) its Tet-catalyzed oxidation products (5hmC, 5fC, and 5caC) in the absence of maintenance DNA methylase DNMT1 or Tet hydroxylase, respectively. Active DNA demethylation mechanisms comprise (iii) active removal of 5mC via Tet3-catalyzed oxidation products involving activity of yet unidentified deaminase (\*) and DNA glycosylases feeding into the BER pathway or (iv) direct removal of 5mC independent of Tet action involving an unknown deaminase (\*) or demethylase. C, cytosine; T, thymidine; 5hmU, 5-hydroxymethyluracil.](JCB_201807044_Fig2){#fig2}

Our understanding of the regulation and function of DNA methylation during early embryonic development is still limited despite years of intensive research. Extensive and increasing studies show confounding aspects of zygotic DNA methylation dynamics. In 2000, immunofluorescence analysis showed epigenetic asymmetry between the two parental genomes in mouse zygotes: The paternal genome undergoes considerable loss of 5mC before DNA replication commences, while the maternal genome retains a high 5mC level ([@bib105]; [@bib119]). The timing of paternal DNA demethylation---occurring before DNA replication---led to the conclusion that an active mechanism is mediating this event, while the maternal genome is protected from active DNA demethylation ([@bib111]; [@bib57]). The maternal genome undergoes passive, replication-dependent DNA demethylation during subsequent embryonic cleavage divisions ([@bib130]), presumably due to limited availability of DNMT1 ([@bib64]).

The discovery of Tet family proteins stimulated the hypothesis that zygotic active paternal DNA demethylation involves 5mC oxidation. Indeed, the conversion of 5mC to 5hmC is observed on paternal DNA concurrently with 5mC loss in G1 phase ([@bib53]; [@bib68]; [@bib73]; [@bib163]) and is accompanied by the timely appearance of 5fC and 5caC ([@bib69]). Among the Tet protein family members, Tet3 was identified to act predominantly in the mouse zygote. Depletion of Tet3 by siRNA or *Tet3* conditional maternal knockout showed reduced paternal 5mC loss and abolished 5hmC accumulation in S/G2 phase zygotes ([@bib53]; [@bib163]; [@bib70], [@bib71]; [@bib154]). Immunofluorescence-based detection of cytosine modifications reflects global levels and does not allow discrimination between loci-specific 5mC loss by its oxidation followed by active excision and replacement by unmodified cytosine, further modifications, or passive dilution by DNA replication.

Recent progress in the generation of low-input genomic DNA methylation profiles is creating a distinct picture of zygotic DNA demethylation. Reduced representation bisulfite sequencing (RRBS) data revealed that both parental genomes are subjects of DNA demethylation, which is mediated primarily by passive replication-dependent dilution and to a lesser extent by active Tet3-dependent mechanisms ([@bib54]; [@bib138]). This conclusion is supported by RRBS data from zygotes that were chemically inhibited to undergo DNA replication and postreplicative maternal *Tet3* knockout zygotes. The RRBS results are apparently in contrast to the previous immunofluorescence-based observations, which led to the conclusion that 5mC loss occurs predominantly in the paternal genome with strong involvement of Tet3 activity ([@bib105]; [@bib119]; [@bib53]; [@bib163]; [@bib70], [@bib71]; [@bib154]). The discrepancy could in part be attributed to the enrichment for CpG-rich regions (bias to CpG islands) and the low genome coverage of 2--5% of all CpG sites in the RRBS data ([@bib54]; [@bib138]). Whole-genome bisulfite sequencing can overcome a selective view on CpG methylation and was applied to wild-type and maternal *Tet3* knockout zygotes ([@bib121]). The majority (90%) of paternal intergenic regions and gene bodies are demethylated, and Tet3 does play a noteworthy, if only moderate, role in DNA demethylation at all genomic features ([@bib121]). Interestingly, the whole-genome bisulfite sequencing data indicate an involvement of Tet3 in maintenance of the hypomethylated state of some CpG islands ([@bib121]). This is further supported by qualitative (immunofluorescence) and impressive quantitative (liquid chromatography--mass spectrometry) data ([@bib3]) showing DNMT3a- and DNMT1-driven accumulation of paternal 5hmC on de novo--generated 5mC in postreplicative zygotes. This may partially explain why some paternal 5mC is detected by immunofluorescence staining in late Tet3-depleted zygotes, which was previously interpreted as remaining 5mC due to impaired DNA demethylation ([@bib53]; [@bib163]; [@bib70], [@bib71]; [@bib154]).

Nevertheless, only a fraction of the paternal genome appears to undergo Tet3-independent DNA demethylation ([@bib54]; [@bib121]; [@bib138]). Whether this is solely mediated by DNA replication--dependent dilution of 5mC is challenged by recent observations that global 5mC loss occurs (a) temporally uncoupled from DNA replication in G1 phase and (b) before, as well as independently of, Tet3-mediated 5hmC accumulation ([@bib3]; [@bib92]). The mechanism underlying this active and potential Tet3-independent DNA demethylation remains to be identified. Further work is necessary to understand zygotic Tet3-dependent active DNA demethylation since mouse knockout studies demonstrated that thymine-DNA glycosylase is not essential in zygotic active DNA demethylation ([@bib134]; [@bib54]). Interestingly, mutations of several known DNA glycosylases result in viable mice that lack an obvious phenotype, suggesting redundant mechanisms ([@bib47]). A contribution of a BER-coupled pathway in zygotic active DNA demethylation is supported by preferential localization of BER proteins to the paternal pronucleus ([@bib57]; [@bib162]). Maternal knockout of the essential BER component Xrcc1 leads to accumulation of paternal DNA lesions during active DNA demethylation, demonstrating that Xrcc1 is required for their timely repair ([@bib92]). Furthermore, cohesin is necessary for the repair of endogenous paternal DNA lesions, which are generated by a mechanism requiring Tet3 activity ([@bib92]).

Currently, four mechanisms of zygotic DNA demethylation that might act redundantly and potentially possess specificity for certain genomic regions have been proposed ([Fig. 2](#fig2){ref-type="fig"}): (i) replication-dependent passive dilution of 5mC, (ii) replication-dependent passive dilution of oxidized 5mC (5hmC, 5fC, and 5caC), (iii) active removal of 5mC via Tet3-catalyzed oxidation products 5hmC, 5fC, and 5caC, and (iv) active removal of 5mC that is independent of Tet3 activity. The generation of extensive genomic profiles for zygotic 5mC and its oxidation products from staged zygotes (pre- versus post-replication) including separate analysis of parental genomes under conditions of Tet3 perturbation will help to further elucidate the intricate picture of DNA methylation dynamics and Tet3 function in early embryonic development. Of certain interest will be whether active DNA demethylation or 5hmC formation occurs at specific genomic regions to potentially establish a permissive chromatin state that may facilitate the acquisition of totipotency.

Biological relevance of zygotic DNA methylation dynamics {#s05}
========================================================

It remains to be determined whether zygotic DNA demethylation plays an essential role in mammalian development and contributes to the acquisition of totipotency. Intriguingly, DNA demethylation is observed in mammalian embryos from a range of species including mouse, rat, goat, bovine, and human ([@bib105]; [@bib119]; [@bib29]; [@bib49]; [@bib120]; [@bib95]; [@bib163]; [@bib40]). Some species have been reported to not display zygotic DNA demethylation, like pig and sheep ([@bib9]; [@bib79]). An extensive analysis of zygotic DNA methylation dynamics using different methods of detection in a multitude of mammalian species is still missing and might support either conserved or species-specific roles of DNA methylation during development.

Increasing evidence supports a role of 5mC in gene suppression ([@bib82]; [@bib135]), but the function of its oxidized forms remains elusive ([@bib140]). Some studies attempted to correlate ZGA with DNA demethylation and Tet3-mediated 5mC oxidation ([@bib70]; [@bib121]; [@bib138]; [@bib154]; [@bib174]). Global analysis of zygotic transcription using semi-quantitative detection of incorporated UTP analogue or transcriptome analysis by RNA-seq in *Tet3* knockdown or knockout zygotes, respectively ([@bib70]; [@bib121]; [@bib138]), suggests that Tet3 is dispensable for zygotic transcription. Additionally, a positive correlation of genes within demethylated paternal loci in the zygote to increased expression in the two-cell embryo does not change remarkably upon maternal Tet3 depletion ([@bib121]), indicating that the majority of genes undergoing demethylation, and thus potential priming for ZGA, appear to do this in a Tet3-independent manner.

Nonetheless, it needs to be taken into account that bisulfite-based techniques cannot distinguish 5mC from 5hmC and unmodified cytosine from 5fC or 5caC ([@bib66]; [@bib80]; [@bib114]; [@bib170]; [@bib13]). Therefore, a subset of genes that might be marked with 5hmC or its further oxidized forms would not be identified. Furthermore, the detection of oxidized 5mC is challenging due to their low abundance ([@bib75]) suggesting that these either are transient in nature or have a function at specific CpG islands. A recent methodological advance using chemical labeling--enabled C-to-T conversion sequencing that covers 15--27% of CpGs ([@bib174]) provided insights into the genomic distribution of 5fC in gametes and zygotes. Interestingly, 5fC is enriched at promoters, while its distribution among other genomic features is heterogeneous in the zygotic genome. Gene ontology analysis of promoters enriched for 5fC identified clusters of genes that are important for preimplantation development ([@bib174]), suggesting a regulatory role for 5fC in ZGA. Whether 5fC sites represent an intermediate stage toward cytosine demethylation or are directly involved in gene activation needs further investigation. Both scenarios are in principle possible since 5fC is associated with recruitment of DNA repair factors as well as transcriptional regulators ([@bib76]; [@bib144]). A role of Tet3 in ZGA may be conceivable since evidence emerged that Tet3 partially restricts global transcription in late zygotes ([@bib154]). Nevertheless, currently there is no clear evidence for a specific role of Tet3 in regulating ZGA.

Considering that Tet3 is the major enzyme catalyzing 5mC oxidation in zygotes, together with its intricate role in DNA demethylation, it seems surprising that maternal Tet3 depletion results in no obvious defects in the preimplantation blastocyst, but rather in neonatal sublethality ([@bib53]; [@bib138]; [@bib71]). Elegant nuclear transfer experiments showed that Tet3-mediated paternal 5mC oxidation is not required for embryonic development to term and that Tet3 haploinsufficency likely causes sublethality ([@bib71]). However, it was not addressed whether Tet3-dependent changes on the maternal genome are crucial for full-term development, nor whether redundant mechanisms compensate for Tet3 loss in the early zygote. The other two known Tet protein family members (Tet1 and Tet2)---despite being poorly expressed in the zygote ([@bib53]; [@bib73]; [@bib163])---might act redundantly in the absence of Tet3. Interestingly, CpG islands are hypermethylated and gene expression is perturbed in Tet1/2/3 knockout embryos, which develop morphologically normally until gastrulation ([@bib28]). This is in line with the role of Tet3 in protecting against 5mC accumulation in the zygote ([@bib121]; [@bib3]), but does not exclude a function of Tet1/2 in maintenance of a hypomethylated state. The scarcity of early mammalian embryos as an in vivo model to study the role of dynamic DNA methylation has thus far prevented the generation of high-coverage genome-wide DNA methylation profiles. Further improvement of low-input techniques might be able to reveal whether Tet3-dependent gene regulation is set at distinct loci already in the zygote or later in development.

Integrating nuclear architecture with zygotic reprogramming {#s06}
===========================================================

Revealing higher-order chromatin structure in the early embryo {#s07}
--------------------------------------------------------------

The scarcity of material provides a challenge for analyzing genome architecture in totipotent early embryos. Studies of nuclear architecture in zygotes have hitherto been focused on nuclear subcompartments, which can be visualized in single cells by microscopy such as immunofluorescent detection of candidate proteins or FISH of genomic loci. Well-studied examples of subnuclear compartments include the nuclear envelope and lamina, nucleoli, promyelocytic leukemia and Cajal bodies, euchromatin and heterochromatin, and chromosome territories (reviewed in [@bib14]).

The advances of genome-wide profiling of chromatin interactions (see text box) are revolutionizing the study of chromatin reprogramming in the early embryo. In 2017, four studies used high-throughput sequencing-based chromatin conformation capture methods (Hi-C) to detect higher-order chromatin structures in early mouse embryos ([@bib38]; [@bib44]; [@bib51]; [@bib86]). Topologically associating domains (TADs) can be detected from the zygote stage onward ([@bib44]; [@bib51]) and become more pronounced, displaying increased intra-domain interactions between distal regions and progressive insulation around TAD boundaries during the course of embryonic cleavage divisions ([@bib38]; [@bib51]; [@bib86]). This suggests a gradual shift toward a somatic cell-like chromatin state. It is not known whether this difference in TAD boundary insulation functionally correlates to the transition of totipotency toward lineage specification or might reflect an initial shortage of factors required for TAD formation that steadily increases with the onset of ZGA. Since TADs can be detected before minor ZGA in unperturbed G1 phase zygotes ([@bib44]; [@bib51]), TAD formation does not strictly depend on transcription. Chemical inhibition of transcription in mouse zygotes as well as in the fly embryo is consistent with this ([@bib38]; [@bib67]; [@bib86]).

###  {#s08}

#### Importance and description of higher-order chromatin structure {#s09}

Cellular identity and plasticity is mediated by differential gene expression that orchestrates the interplay of transcription factors, DNA sequence, and epigenetic modifications ([@bib131]; [@bib141]; [@bib37]). This regulatory network is becoming conceptually extended by incorporating the spatial and temporal organization of the genome. Accommodation of the 2-m-long DNA into the three-dimensional nucleus of mammalian cells is non-random and cell type specific, implying a functional relevance of chromatin organization ([@bib11]; [@bib31]). Indeed, the three-dimensional arrangement of linear DNA can bring distal cis-regulatory elements, like enhancers or insulators, into close proximity with their target genes ([@bib52]; [@bib139]).

The elucidation of higher-order nuclear architecture became experimentally amenable with the development of biochemical approaches that map physical genome interactions by DNA--DNA proximity ligation. These chromosome conformation capture assays, so called "C" techniques (3C, 4C, 5C, Hi-C, and derivatives; reviewed in [@bib32]) revealed multi-hierarchical structuring of chromatin. Thus, interphase chromatin is organized into loops, TADs, and compartments ([@bib99]; [@bib124]; [@bib110]):

• **Loops** are formed by close association of two genomic regions that can be far apart in linear sequence and are characterized by closely associated CTCF-based anchor sites.

• **TADs** are large stretches of DNA that display high contact frequency and loci within these are less likely to interact with loci in other TADs. TADs may represent an assembly of dynamic loops, but the detailed relationship between loops and TADs awaits experimental verification.

• **Compartments** are spatially segregated regions that delineate transcriptionally active (A) and repressed (B) regions, which correlate with the chromatin state that is defined by epigenetic modifications.

The zygote stage displays the least defined higher-order chromatin structure during preimplantation development. While the detection of TADs and loops was reported in the parental genomes of the zygote ([@bib44]), two subsequent studies reported weak to nearly undetectable TADs in zygotes ([@bib38]; [@bib86]). The discrepancy was resolved by reanalysis of the bulk Hi-C data ([@bib51]) using algorithms with higher statistical power, which confirmed the presence of TADs and loops in these datasets ([@bib38]; [@bib86]). It is worthwhile to point out that, despite epigenetic differences, TADs and loop strengths are similar between maternal and paternal genomes ([@bib38]; [@bib44]; [@bib51]; [@bib86]). There is the tendency of fewer distal interactions in the paternal genome ([@bib38]), suggesting a more relaxed chromatin state, in line with global hypomethylated DNA and histone modifications associated with transcriptionally active chromatin ([@bib105]; [@bib119]; [@bib20]). The allelic differences in TAD organization become evident upon interfering with one essential protein complex required for TAD formation or maintenance, namely cohesin ([@bib51]; [@bib56]; [@bib59]; [@bib125]; [@bib137]; [@bib167]). Cohesin or its associated proteins are strong candidates for the loop extrusion factor, which has been proposed to progressively facilitate loop growth until encountering a boundary element ([@bib113]; [@bib2]; [@bib133]; [@bib48]). Depletion of the cohesin-release factor Wapl affects the processivity of cohesin, which has different effects on parental chromatin structure: The maternal genome displays stronger compaction with longer loops, while loops and TAD insulation are stronger in the paternal genome ([@bib51]). This might indicate that loop extrusion dynamics in the parental genomes are different due to the underlying asymmetry of their epigenetic landscapes.

Interestingly, maternal and paternal chromatin structure are most distinct with respect to compartmentalization, which is weak or absent in zygotic maternal chromatin ([@bib38]; [@bib44]; [@bib51]; [@bib86]). This is of general interest because it suggests that establishment of compartments follows a different mechanism than TAD and loop formation. Indeed, the mechanism of TAD formation involves cohesin and thus loop extrusion, which are not required for and even antagonize compartmentalization ([@bib51]; [@bib56]; [@bib59]; [@bib125]; [@bib137]; [@bib167]). In addition, the dynamics of TAD and compartment formation differ during the cell cycle of mESCs ([@bib110]). TAD insulation strength increases in G1 phase and reaches a plateau in S phase, while compartmentalization is weak in G1 and steadily increases from S phase onward until it reaches its maximum in G2 phase ([@bib110]). Assuming that higher-order chromatin structure is reestablished after every mitotic phase, one might expect that the maternal zygotic genome reestablishes chromatin conformation after completion of the second meiotic division, while the paternal genome might require de novo establishment of chromatin architecture after protamine--histone exchange ([Fig. 1](#fig1){ref-type="fig"}). Surprisingly, the maternal genome does not rapidly establish compartments after chromosome decondensation, while the paternal genome displays compartmentalization in G1-phase zygotes ([@bib44]). This raises the question whether compartmentalization is inherited and/or simply established faster in the paternal genome. Potentially, a predetermined architecture might facilitate formation of paternal compartments after fertilization. Unexpectedly, bulk Hi-C data show that sperm chromatin conformation does not drastically differ from other mammalian cells apart from displaying increased long-range interactions and inter-chromosomal contacts, which are consistent with a compact chromatin state ([@bib8]; [@bib84]). Single-cell sperm Hi-C data is needed to confirm these observations. A driving force for fast compartmentalization could be transcription since it is assumed that the paternal genome is more permissive for early transcription ([@bib161]; [@bib4]). Precise future experiments might shed light on whether epigenetic modifications and early transcription are required for paternal compartmentalization or vice versa.

Then again, a puzzling question is: What is special about the maternal chromatin and the lack of compartmentalization? Or, what are the prerequisites for de novo compartmentalization? Little is known about the actual mechanism behind formation of compartments. One hypothesis suggests that phase separation based on direct protein--protein interactions in the framework of epigenetic signatures drives segregation of chromatin types ([@bib16]; [@bib33], [@bib34]). Thus, the epigenetic asymmetry of histone modifications and DNA methylation in the parental genomes might account for distinct compartmentalization. The absence of maternal compartments might therefore be caused by the presence of factors specifically interacting with the maternal epigenome to prevent segregation of chromatin types. Alternatively, loop extrusion dynamics in the maternal genome might antagonize compartmentalization. Further investigations are required to delineate the determinants of de novo compartmentalization. An exciting topic of future research will be to determine whether there is a causal relationship between the epigenome and higher-order chromatin structure.

The role of chromatin accessibility in preparing for ZGA {#s10}
========================================================

A more direct relationship of epigenetic modifications, transcription factor occupancy, and gene expression can be inferred when moving from global higher-order chromatin organization toward primary nucleosomal chromatin structure. The nucleoprotein structure of chromatin is the smallest unit guiding differential gene expression. Nucleosome positioning defines general chromatin accessibility ([@bib123]; [@bib132]), while the four core histones of the octamer comprising the nucleosome carry post-translational modifications that can affect DNA binding affinity and serve as a binding platform for regulatory factors ([@bib109]).

The chromatin accessibility landscape of the early embryo is of great interest to identify pioneer transcription factors that may be important for the acquisition of totipotency ([@bib172]; [@bib77]; [@bib171]). Pioneer factors are hypothesized to be critical for ZGA by initiating or priming regulatory events at closed chromatin regions to promote transcription. There are different modes of action. In its simplest form, a pioneer factor binds to closed chromatin, alters chromatin accessibility, and either directly initiates transcription or primes the genomic locus for other transcription factors. Pioneer factors have essential roles in cell fate transitions, such as hepatic differentiation of embryonic gut endoderm or B cell development from hematopoietic progenitors ([@bib172]; [@bib77]; [@bib171]). The best studied pioneer factor in early embryonic development is the fly protein Zelda ([@bib146]; [@bib98]). Zelda can facilitate transcription directly or indirectly ([@bib60]; [@bib136]; [@bib147]) and was shown to affect chromatin conformation ([@bib67]). However, a mammalian counterpart has not been identified. Interestingly, Oct4 and Sox2 homologues are important for ZGA in zebrafish ([@bib93]; [@bib94]) and have been shown to bind to closed chromatin to induce cellular reprogramming during mammalian induced pluripotent stem cell generation ([@bib142], [@bib143]; [@bib90]; [@bib36]). However, Oct4 functions as a lineage specifier in mammalian embryos ([@bib115]; [@bib45]) that contributes to increased chromatin accessibility after ZGA in the eight-cell mouse embryo ([@bib101]). Recently, the double homeobox transcription factor Dux emerged as a novel regulator of mammalian ZGA ([@bib30]; [@bib62]; [@bib159]). Dux expression coincides with ZGA. Chromatin immunoprecipitation (ChIP) data indicate that Dux preferentially binds to genes that are specific for early cleavage-stage embryos. The binding profile of Dux overlaps with chromatin accessibility profiles, further supporting its transcriptional role. Overexpression of Dux in mESCs induces transition to two-cell--like cells, which have a gene expression signature that to some extent resembles two-cell embryo blastomeres ([@bib103]; [@bib74]; [@bib39]). A comparison of chromatin accessibility profiles of two-cell embryos and Dux-induced two-cell--like cells showed a correlation of accessible sites gained and lost upon mESC transition ([@bib62]). Interestingly, half of the gained accessible sites are bound by Dux, suggesting that Dux might act as a pioneer factor to open chromatin. It remains to be shown whether Dux is able to directly bind to closed chromatin and mediate its opening. Additionally, it is not known what mechanisms regulate Dux transcription in the early embryo. LINE1 RNA was recently shown to contribute to Dux silencing in mESCs and early embryos ([@bib122]). The existence of a yet unidentified upstream pioneer factor remains a likely possibility.

The identification of pioneer factors is thus far based on approaches aimed at identifying early binding factors in cellular transitions by ChIP or in vivo footprinting. ChIP-based approaches can generate genome-wide binding profiles, but are limited by assaying known candidate factors. Genome-wide in vivo chromatin accessibility assays, like micrococcal nuclease sensitive sites sequencing (MNase-seq), DNase I hypersensitive sites sequencing (DNase-seq), formaldehyde-assisted isolation of regulatory elements sequencing (FAIRE-seq), and assay for transposase-accessible chromatin sequencing (ATAC-seq; reviewed in [@bib153]), can reveal sequence motifs for factors that bind to open chromatin. Zelda in *Drosophila melanogaster* and Dux in mammals were identified by motif analysis in a similar fashion ([@bib146]; [@bib98]; [@bib30]; [@bib62]; [@bib159]).

Recent advances in low-input chromatin accessibility assays ([@bib18]; [@bib26]; [@bib81]) make it feasible to analyze accessible chromatin in early embryos. Data have been gathered from cleavage stage embryos ([@bib101]; [@bib165]). Low-input DNase-seq and ATAC-seq techniques led to the discovery that parental genomes are similar in their chromatin accessibility profiles from genome activation in the two-cell mouse embryo onward ([@bib101]; [@bib165]), despite epigenetic asymmetry up to the eight-cell stage. Interestingly, open chromatin sites are increasing during cleavage stages in mouse and human embryos ([@bib101]; [@bib165]; [@bib50]; [@bib97]), suggesting a gradual establishment during development. On the contrary, microscopy-based and Hi-C techniques suggest a rather permissive and open chromatin state in one-cell and two-cell embryos ([@bib1]; [@bib38]; [@bib44]; [@bib51]; [@bib86]). However, microscopy and Hi-C reveal different levels of chromatin organization and can be used to shed light on higher-order structure, while DNase-seq and ATAC-seq reflect the primary chromatin structure of nucleosome and transcription factor occupancy. Thus, a rather susceptible and open higher-order chromatin structure does not necessarily imply an underlying general loose nucleosome array. DNase hypersensitive sites (DHSs) are mainly detected at promoters and distal regulatory regions. Detection at distal elements predominates at two-cell-- and eight-cell--stage embryos ([@bib101]), correlating to major ZGA and priming for lineage specification around the morula stage, respectively. Of note, the presence of DHS does not automatically indicate expression. Transcriptomic data have also revealed DHS sites at silent genes that are primed for expression at a subsequent developmental stage ([@bib101]). Chromatin accessibility profiles identified putative regulatory elements that are part of the transcriptional networks accompanying early embryonic development. For example, the nuclear transcription factor Y α was shown to be involved in ZGA ([@bib101]), and Nr5a2 (nuclear receptor subfamily 5, group A, member 2) regulates lineage specification ([@bib165]).

Nevertheless, the questions of which genomic loci open up first after fertilization and how this is mediated remain to be answered. The challenge of experimental timing during embryo development and separation of data originating from the two parental genomes will be possible to overcome. In vitro fertilization can provide control of fertilization timing, while extraction of zygotic pronuclei or use of parental mice strains with distinct single-nucleotide polymorphisms can be used to separate the parental genomes. An interesting dataset was generated from late zygotes (S/G2 phase) applying pronuclear extraction and low-input DNase-seq ([@bib72]). Most accessible chromatin sites are similar between parental genomes, but a fraction displays allelic specificity that correlates with allelic gene expression profiles. Whether these sites might resemble loci primed for ZGA and potentially harbor information about putative pioneer factors of early embryonic development needs to be determined. However, it might be important to study zygotes at an earlier cell cycle stage in which putative pioneer factors might take first action and to test their ability to initiate a regulatory response that facilitates a totipotent state.

Perspectives {#s11}
============

Recent technological advances in genome-wide low-input assays are starting to describe the chromatin state of the totipotent embryo. These will expand to obtain a comprehensive and detailed picture of embryonic histone modifications, DNA modifications, chromatin accessibility, and higher-order chromatin structure. Ultimately, functional assays will have to be developed to test the importance of the in vivo chromatin state for totipotency and developmental potential. Genetic perturbation experiments using maternal knockout strategies of candidate factors have great power to shed light on the essential regulators of early embryonic development. Thus, maternal-effect genes can be identified that are maternal factors nonessential for oogenesis but critical for embryonic development ([Table 2](#tbl2){ref-type="table"}). Genetic engineering is becoming easier with the advance of the CRISPR-Cas system ([@bib24]; [@bib158]). This may facilitate screening for pioneer factors that initiate a totipotent state by allowing cooperative action of a set of factors important for ZGA. The identification of such factors in *Drosophila* and zebrafish embryos ([@bib146]; [@bib93]; [@bib94]) led to the assumption that mammalian counterparts exist. Pioneer factors might function not only by promoting transcription but also by inhibiting other transcriptional programs. This is exemplified through the role of Myt1l (myelin transcription factor 1-like) in protecting neuronal identity by repressing somatic lineage programs and allowing neuronal-specific transcription ([@bib104]). It is possible that such transcriptional repressors also act during acquisition of totipotency to inhibit a multitude of differentiation programs.

###### Maternal-effect genes found by genetic perturbation experiments with predominant developmental arrest at the zygote stage

  **Gene/aliases**                                                **KD/KO**                                    **Developmental role**                                                                                               **References**
  --------------------------------------------------------------- -------------------------------------------- -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  Gas6/growth arrest specific 6                                   KD by RNAi                                   Maternal cytoplasmic maturation, sperm chromatin decondensation, pronuclear formation                                [@bib88], [@bib89]
  Hira/histone cell cycle regulation defective homolog A          cKO using *(Tg)Zp3-Cre* and *(Tg)Gdf9-Cre*   Transcription, replication, paternal nucleosome assembly                                                             [@bib100]; [@bib112]
  Npm2/nucleoplasmin 2                                            KO                                           Nuclear and nucleolar organization, chromatin remodeling                                                             [@bib19]
  Scc1 (Rad21)/double-strand-break repair protein rad21 homolog   cKO using *(Tg)Zp3-Cre*                      Mitotic sister chromatid cohesion, repair of Tet3-dependent paternal DNA lesions, higher-order chromatin structure   [@bib92]; [@bib51]
  Zar1/zygote arrest 1                                            KO                                           RNA processing, pronuclear fusion                                                                                    [@bib166]; [@bib65]
  Ago2/argonaute 2, RISC catalytic component                      cKO using *(Tg)Zp3-Cre*                      miRNA homeostasis, post-transcriptional gene silencing of maternal factors                                           [@bib85]; conflicting arrest after two-cell ([@bib108]; [@bib102])
  Hsf1/heat shock factor 1                                        KO                                           Transcription, redox-homeostasis                                                                                     [@bib22]; [@bib12]

cKO, conditional KO; KD, knockdown.

Next to in vivo functional assays addressing the interplay of chromatin state and developmental potential, insights may be gained from in vitro modeling. Considering the hypothesis of phase separation--guided genome compartmentalization, one can speculate that the epigenetic state of nucleosomes can be used to predict higher-order chromatin structure. Indeed, such a prediction has been computationally tested by integrating an array of several epigenetic markers in neuronal cells ([@bib34]). Nevertheless, how chromatin is organized in the embryonic interphase nucleus remains a fascinating subject for ongoing work. Advances in low-input ChIP ([@bib27]; [@bib173]) will help to define the epigenome of early embryos and might allow computational de novo modeling of higher-order chromatin structure.

We are now entering a new dimension to study fundamental biological processes such as cellular plasticity in sparse cells of the early embryo. How chromatin is reprogrammed to totipotency within hours after fertilization remains a central question in biology. A combination of mechanistic cell biology with genetics and genomics will shed light on how chromatin reorganization promotes totipotency and the essential regulators for this dramatic cell fate transition.
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